MedTrace Logo

BIBR 277 Capsule in Patients With Essential Hypertension

NCT02177448 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2014-07-08

No results posted yet for this study

Summary

The efficacy and safety of Telmisartan capsule in patients with essential hypertension were evaluated in comparison with Enalapril Maleate in the double blind trial.

Conditions

Interventions

DRUG

BIBR277 low dose

DRUG

BIBR277 medium dose

DRUG

BIBR277 high dose

DRUG

Enalapril low dose

DRUG

Enalapril medium dose

DRUG

Enalapril high dose

DRUG

Placebo matching BIBR277

DRUG

Placebo matching enalapril

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-09-30
Primary Completion
1999-09-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02177448 on ClinicalTrials.gov